| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/09/2004 | DE10323096A1 Verfahren zur Untersuchung eines Wirkstoffeinflusses auf biologische Zellen A method for investigating a drug influence on biological cells |
| 12/09/2004 | DE10160983B4 Verfahren und Integrierte Vorrichtung zum Nachweis von Cytosinmethylierungen Integrated method and apparatus for detection of cytosine methylations |
| 12/09/2004 | CA2809131A1 Use of s1p |
| 12/09/2004 | CA2567823A1 In vitro platform for screening agents inducing islet cell neogenesis |
| 12/09/2004 | CA2527907A1 Double-stranded hairpin rnas for rnai |
| 12/09/2004 | CA2527819A1 Optical sensors based on hybrid aptamer/conjugated polymer complexes |
| 12/09/2004 | CA2527571A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 12/09/2004 | CA2527296A1 Imageable animal model of sars infection |
| 12/09/2004 | CA2527179A1 Ecdysone receptor ligand-binding domain structure |
| 12/09/2004 | CA2526533A1 High-throughput methods of screening dna for deletions and other mutations |
| 12/09/2004 | CA2525681A1 Crystals and structures of c-abl tyrosine kinase domain |
| 12/09/2004 | CA2525540A1 Enterococcus antigens |
| 12/09/2004 | CA2523716A1 Human anti-human cd3 binding molecules |
| 12/08/2004 | EP1484706A2 Method for estimating effect of working substance and screening method |
| 12/08/2004 | EP1484615A2 Method for detecting fibrinogen and/or fibrinogen derivatives |
| 12/08/2004 | EP1484416A2 Method of identifying and quantifying specific fungi and bacteria |
| 12/08/2004 | EP1484415A2 Method of alleviating pest infestation in plants |
| 12/08/2004 | EP1484414A1 Reagent for measuring alanine aminotransferase activity |
| 12/08/2004 | EP1484413A1 Assay for identifying inhibitors of Mycobacterium anti-oxidant defense system |
| 12/08/2004 | EP1484412A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof |
| 12/08/2004 | EP1484399A1 Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same |
| 12/08/2004 | EP1484394A1 Primers for nucleic acid amplification in detecting housekeeping gene mrna and test method using these primers |
| 12/08/2004 | EP1484340A1 Antibodies to a novel mammalian protein associated with uncontrolled cell division |
| 12/08/2004 | EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 12/08/2004 | EP1484337A2 Methods, kits and compositions pertaining to linear beacons |
| 12/08/2004 | EP1484111A1 Dry solid medium for storage and analysis of genetic material |
| 12/08/2004 | EP1484067A2 Cancer control |
| 12/08/2004 | EP1483775A1 A plasma mass spectrometer |
| 12/08/2004 | EP1483720A1 Computer systems and methods for identifying genes and determining pathways associated with traits |
| 12/08/2004 | EP1483590A1 Positioning system for moving a selected station of a holding plate to a predetermined location for interaction with a probe |
| 12/08/2004 | EP1483588A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 12/08/2004 | EP1483587A2 Tagging and recovery of elements associated with target molecules |
| 12/08/2004 | EP1483585A1 Encoded self-assembling chemical libraries (esachel) |
| 12/08/2004 | EP1483582A1 Dissociative fluorescence enhancement assay |
| 12/08/2004 | EP1483581A2 Population based assessments and means to rank the relative immunogenicity of proteins |
| 12/08/2004 | EP1483576A2 Novel method for detecting and analyzing protein interactions in vivo |
| 12/08/2004 | EP1483575A2 Methods for isolating ligands e.g. t cell epitopes |
| 12/08/2004 | EP1483561A2 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 12/08/2004 | EP1483511A2 Cell viability detection using electrical measurements |
| 12/08/2004 | EP1483428A1 Diamond electrode |
| 12/08/2004 | EP1483416A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 12/08/2004 | EP1483415A2 A non-invasive diagnostic test utilizing histone modification markers |
| 12/08/2004 | EP1483414A2 Method and apparatus for synthesis of arrays of dna probes |
| 12/08/2004 | EP1483413A2 Use of capturing probes for identifying nucleic acids |
| 12/08/2004 | EP1483412A2 Facl4 and mutation thereof in x-linked mental retardation syndrome |
| 12/08/2004 | EP1483411A2 Improvements in and relating to marking |
| 12/08/2004 | EP1483410A1 Method and device for determination of tissue specificity of free floating dna in bodily fluids |
| 12/08/2004 | EP1483409A1 Method of error reduction in nucleic acid populations |
| 12/08/2004 | EP1483408A1 Nanostructures containing pna joining or functional elements |
| 12/08/2004 | EP1483406A1 Headloop dna amplification |
| 12/08/2004 | EP1483405A2 METHODS OF VALIDATING SNPs AND COMPILING LIBRARIES OF ASSAYS |
| 12/08/2004 | EP1483404A2 Methods for detecting genome-wide sequence variations associated with a phenotype |
| 12/08/2004 | EP1483403A2 Enzymatic ligation-based identification of nucleotide sequences |
| 12/08/2004 | EP1483402A1 Apparatus and method for amplifying a polynucleotide |
| 12/08/2004 | EP1483401A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors |
| 12/08/2004 | EP1483400A1 Use of the axl receptor for diagnosis and treatment of renal disease |
| 12/08/2004 | EP1483399A2 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 12/08/2004 | EP1483391A1 Engineered baculoviruses and their use |
| 12/08/2004 | EP1483389A2 Genetic products differentially expressed in tumors and use thereof |
| 12/08/2004 | EP1483384A2 Method for overexpression of zwitterionic polysaccharides |
| 12/08/2004 | EP1483381A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 12/08/2004 | EP1483380A2 Recombinant protein c variants |
| 12/08/2004 | EP1483376A1 High throughput system for producing recombinant viruses using site-specific recombination |
| 12/08/2004 | EP1483371A1 Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues |
| 12/08/2004 | EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 12/08/2004 | EP1483288A2 Hbm variants that modulate bone mass and lipid levels |
| 12/08/2004 | EP1483283A1 Modulation of protein methylation and phosphoprotein phosphate |
| 12/08/2004 | EP1483281A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 12/08/2004 | EP1483048A2 Microarray synthesis instrument and method |
| 12/08/2004 | EP1483029A2 Selective elution of immobilized multiplexed primer extension products |
| 12/08/2004 | EP1482989A1 Inactivation of microbes in biological fluids |
| 12/08/2004 | EP1482973A1 Methods of modulating cd200 receptors |
| 12/08/2004 | EP1482969A2 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequence |
| 12/08/2004 | EP1482956A1 Targeted drug delivery methods |
| 12/08/2004 | EP1482803A2 Plant preparations |
| 12/08/2004 | EP1482793A2 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 12/08/2004 | EP1482779A2 Heat stable mutants of starch biosynthesis enzymes |
| 12/08/2004 | EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor |
| 12/08/2004 | EP1421175A4 Polymer stabilized proteinases |
| 12/08/2004 | EP1386150A4 Insect ammunition vectors and methods of use to identify pesticide targets |
| 12/08/2004 | EP1330553A4 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 12/08/2004 | EP1266033A4 Method of reverse transcription using bacillus steraothermophilus or thermoactinomyces vulgaris dna polymerase |
| 12/08/2004 | EP1240355A4 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 12/08/2004 | EP1230385A4 Marker assisted identification of a gene associated with a phenotypic trait |
| 12/08/2004 | EP1222210A4 Immunological assay for detection of antibodies in celiac disease |
| 12/08/2004 | EP1214448A4 A rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 12/08/2004 | EP1194592A4 Derivative nucleic acids and uses thereof |
| 12/08/2004 | EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 12/08/2004 | EP1027364B1 Pyrimidine derivatives for labeled binding partners |
| 12/08/2004 | EP1020533B1 Method for judging the possibility of the onset of sheep leukemia |
| 12/08/2004 | EP1012340A4 Genotyping of human cyp3a4 |
| 12/08/2004 | EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 12/08/2004 | EP0970239B1 Detection of microbial metabolites |
| 12/08/2004 | EP0833941A4 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 12/08/2004 | CN2662241Y Biological enzyme electrode for biosensor |
| 12/08/2004 | CN1554025A Cell-based detection and differentiation of disease states |
| 12/08/2004 | CN1554021A A novel cancer marker and uses therefor in the diagnosis of cancer |
| 12/08/2004 | CN1553962A System for detecting protease |
| 12/08/2004 | CN1553956A Novel genetic products of ashbya gossypii, associated with transmembrane transport |
| 12/08/2004 | CN1553953A Real-time sequence determination |